Retroperitoneal Ligation of Uterine Artery in Total Laparoscopic Hysterectomy for Enlarged Uterus
NCT ID: NCT03101098
Last Updated: 2019-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
54 participants
INTERVENTIONAL
2017-04-10
2020-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of TLH and LAVH With Over Than 500g
NCT03146299
2-D and 3-D Laparoscopic Hysterectomy
NCT02610985
3-dimensional Versus 2-dimensional Laparoscopy for Hysterectomy
NCT04070872
Tissue Removal During Hysterectomy: The Effect of Vaginal Versus Abdominal Morcellation on Surgical Outcomes
NCT02703246
Transvaginal Sacrospinous Hysteropexy Versus Laparoscopic Uterine Lateral Suspension
NCT05586984
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retroperitoneal hysterectomy
In subjects allocated to the experimental group, which the uterine vessels were ligated where it originates from the internal iliac artery,
Retroperitoneal liagation of uterine artery
the site of ligation of uterine artery is the area that it originates from the internal iliac artery during TLH
Classical hysterectomy
The operative technique of classical total laparoscopic hysterectomy (TLH) performed in the control group was comparable to that of retroperitoneal TLH, except for one that coagulation and transection of uterine artery was achieved using an energy device alongside the cervix
Classical ligation of uterine artery
the site of ligation of uterine artery is the area alongside the cervix
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Retroperitoneal liagation of uterine artery
the site of ligation of uterine artery is the area that it originates from the internal iliac artery during TLH
Classical ligation of uterine artery
the site of ligation of uterine artery is the area alongside the cervix
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* uterine volume between 12 and 18 weeks of gestation by pelvic examination
* appropriate medical status for laparoscopic surgery (American Society of Anesthesiologists Physical Status classification 1 or 2)
Exclusion Criteria
* any major medical comorbidities or psychiatric illnesses, which could affect follow-up and/or compliance
* an inability to understand and provide written informed consent.
19 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kangbuk Samsung Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Taejong Song
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Taejong Song, MD PhD
Role: STUDY_CHAIR
Kangbuk Samsung Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kangbuk Samsung Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-02-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.